Live Chat ×
Skip to main content

Episode 29: PONS - Neurostimulants in the Neurointensive Care Unit

Loading audio, please wait...

Description

The NCS Podcast is partnering with the highly successful Pharmacotherapy of Neurocritical Care Series (PONS) in a limited release to cover pertinent pharmacological topics presented by experts in the field of neurocritical care.

Dr. Mehrnaz Pajoumand, Co-Chair of PONS, is joined by Dr. Salia Farrokh to discuss her presentation in the Pharmacotherapy of Neurocritical Care Series (PONS), "Neurostimulants in the Neurointensive Care Unit."

The NCS Podcast is the official podcast of the Neurocritical Care Society. Our senior producer is Bonnie Rossow. Our host is Fawaz Almufti, and our production staff includes Ramani Balu, Michael Brogan, Joshua Levine, Sarah Stern-Nezer, Benjamin Miller, Starane Shepherd, and Chris Zammit. Our administrative staff include Becca Stickney, Sara Memmen, and Angel Gindele. Music by Mohan Kottapally.





This podcast is sponsored by the TTM Academy program at Penn Medicine, an educational initiative to improve care for patients following cardiac arrest and other neurocritical illness using targeted temperature management. This includes live CME workshops, an on-line video educational program, and a free podcast program. Find out more at www.pennttm.com.

Contributors

  • Salia Farrokh, Pharm.D., BCPS, BCCCP

    Salia Farrokh, PharmD, BCPS, BCCCP is a neuro ICU clinical pharmacist specialist at Johns Hopkins Hospital. Dr. Farrokh received her PharmD degree from Saint John Fisher College, Wegmans School of Pharmacy in Rochester, NY. Her postgraduate training includes residencies in Critical Care and Pharmacy Practice at Yale-New Haven Hospital. Dr. Farrokh’s research interests include effective antiplatelet therapy in neuro intervention patients, optimal pain management in neuro ICU patients, and use of neurostimulants in this setting. Dr. Farrokh is passionate about training and precepting students and residents and is a certified ENLS trainer.